Clinical Trials
59 trialsGNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
AO GENERIUM
Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients
Gadjah Mada University
Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
The First Affiliated Hospital with Nanjing Medical University
A Study of TY-1091 in Patients With Advanced Solid Tumors
TYK Medicines, Inc
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible
Hellenic Society of Hematology
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies
First Affiliated Hospital of Fujian Medical University
68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies
First Affiliated Hospital of Fujian Medical University
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
QureBio Ltd.
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
Shanghai EpimAb Biotherapeutics Co., Ltd.
Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients
Shandong Cancer Hospital and Institute
Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity
Mansoura University
PRECISE CURATE.AI Pilot Clinical Trial
National University Hospital, Singapore
Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements
National University Hospital, Singapore
Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC
LaSanta S A S
A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia
Glycostem Therapeutics BV
A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI
Scandion Oncology A/S
PEN-866 in Patients With Advanced Solid Malignancies
Tarveda Therapeutics
Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies
Taiga Biotechnologies, Inc.
PANTAX-Ib
Scandion Oncology A/S
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
South East Technological University
Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
NK cell
Shenzhen University General Hospital
A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
Accendatech USA Inc.
INSIGHT-2
Royal Marsden NHS Foundation Trust
Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer
ImmunoVaccine Technologies, Inc. (IMV Inc.)
SenPET
University Hospital Tuebingen
SOROCOV
Butantan Institute
Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine
Shenzhen University General Hospital
CH1701
Vietlife Healthcare Corporation
A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer
Hamlet Pharma AB
Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis
Shenzhen Geno-Immune Medical Institute
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
Second Affiliated Hospital, School of Medicine, Zhejiang University
ISIKOK-19
Acibadem University
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
MMIPC
Radboud University Medical Center
Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor
Asclepius Technology Company Group (Suzhou) Co., Ltd.
INTRUST
Clinica Universidad de Navarra, Universidad de Navarra
Nivolumab in Relapsed Pediatric Solid Tumors
Hadassah Medical Organization
Effectivity and Safety of Ultrasound-guided Percutaneously Laser Ablation for Refractory Neoplasms
First Affiliated Hospital of Zhejiang University
Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas
First Affiliated Hospital of Zhejiang University
Effectivity and Safety of Endoscopic Ultrasonography-guided Laser Ablation for Refractory Neoplasms
First Affiliated Hospital of Zhejiang University
Limiting Chemotherapy Side Effects by Using Moxa
East and North Hertfordshire NHS Trust
LON002-002
LondonPharma Ltd.
Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Arno Therapeutics
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors
Hanmi Pharmaceutical Company Limited
Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes
Jichi Medical University
SECAR
Karolinska University Hospital
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
Alaunos Therapeutics